• iRGD-RBC Membranes Improve Neuroblastoma PDT

  2026-09-01

  Wu and colleagues developed iRGD-functionalized red blood cell membrane vesicles to deliver the photosensitizer TPOR for neuroblastoma photodynamic therapy. The biomimetic carrier improved cellular uptake, apoptosis, migration inhibition, and tumor growth control in preclinical models, while also illustrating the need to separate therapeutic efficacy from downstream imaging and characterization workflows.

• Parathyroid hormone (1-34) (human) in VC Models

  2026-09-01

  Use this defined PTH (1-34) peptide fragment to connect receptor signaling, calcium biology, bone remodeling, and CKD-associated valvular calcification assays. The workflow pairs concentration-controlled stimulation with endothelial-to-mesenchymal transition and valvular interstitial cell readouts for more mechanistic disease models.

• SU 5402 Workflows for RTK Signaling Studies

  2026-08-31

  Build reproducible SU 5402 experiments for receptor tyrosine kinase signaling, cancer biology, and phenotype-driven validation. The guide connects acute phosphoproteomics-style readouts with cell cycle arrest, apoptosis assay design, and carefully bounded applications in human sensory-neuron models.

• Nullscript and the Logic of Mechanistic HDAC Research

  2026-08-31

  Nullscript offers translational researchers a distinct way to interrogate HDAC biology: it combines HDAC inhibition with an inactive transcriptional-facilitation profile and reported cardioprotection in a murine ischemia/reperfusion model. This article places those findings alongside a mechanistically rigorous renal injury study and develops a practical framework for cardiac, neurodegenerative, and cancer research without overstating preclinical evidence.

• Thymoquinone in Cardiotoxicity Research

  2026-08-30

  Thymoquinone offers a practical way to connect cardiac function, oxidative stress, ferroptosis, and mitochondrial injury in doxorubicin models. This workflow translates a recent mouse study into controlled formulation, dosing, assay-selection, and troubleshooting strategies for preclinical researchers.

• Cell Senescence β-Galactosidase Staining Kit Workflow

  2026-08-29

  Build a practical, microscopy-ready cellular senescence assay around SA-β-Gal activity in cultured cells and frozen tissue sections. This workflow emphasizes control design, macrophage inflammatory-senescence applications, image-based scoring, and troubleshooting that distinguishes biological signal from staining artifacts.

• Grazoprevir Hydrate: From Potency to Proof

  2026-08-28

  Grazoprevir hydrate is a potent HCV NS3/4A protease inhibitor whose value depends on more than picomolar activity. This article connects mechanism, genotype context, pharmacokinetics, clinical evidence, and assay design to improve translational interpretation.

• Calpain Inhibitor I, ALLN: Practical Guide

  2026-08-28

  Calpain Inhibitor I, ALLN (SKU A2602) provides a DMSO- or ethanol-compatible way to investigate calpain and cathepsin protease activity in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. It is water-insoluble and intended for controlled laboratory experiments only, not for diagnostic, therapeutic, or medical use.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-08-27

  A 2025 study identifies an RXRα/PPARγ/NEDD4 signaling axis through which berberine suppresses SASP-related inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse pathology, foam-cell assays, Smart-seq analysis, and macrophage-targeted RXRα knockdown provides a mechanistic framework for connecting nuclear-receptor activity with ubiquitin-dependent clearance of a GATA4/p62 complex.

• Stat3 in Fyn-Driven Dopaminergic Neurodegeneration

  2026-08-27

  This 2024 zebrafish study identifies Stat3 as a downstream effector linking constitutively active Fyn signaling to dopaminergic neuron loss and microglial inflammation. Its combination of neural-specific genetic activation, live imaging, transcriptomics, and pathway inhibition provides a mechanistic framework for Parkinson’s disease-related functional gene studies.

• Ferroptosis Inducers in Advanced Prostate Cancer

  2026-08-26

  Ghoochani and colleagues show that treatment-resistant prostate cancer models retain expression of key ferroptosis regulators and respond to erastin or RSL3, a glutathione peroxidase 4 inhibitor. Their preclinical data support ferroptosis induction, alone or combined with second-generation anti-androgens, as a strategy for limiting prostate cancer cell growth, migration, and tumor progression.

• Heparin sodium for Coagulation Research

  2026-08-26

  Heparin sodium provides a practical control point for anti-factor Xa activity assays, aPTT measurement, and translational thrombosis workflows. This guide also shows how to use coagulation controls when studying plant-derived nanovesicles, without overstating an unvalidated connection between heparin and Sertoli-cell delivery.

• Direct Mouse Genotyping Kit: PCR Workflow

  2026-08-25

  The Direct Mouse Genotyping Kit supports genomic DNA release and direct PCR amplification from mouse tissue without conventional purification, simplifying routine mouse genetic screening and high-throughput genotyping. It is intended for PCR-based assays, not applications requiring highly purified DNA or unvalidated downstream enzymatic workflows.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-08-25

  This study identifies the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic differentiation in skeletal-muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological screening, mass cytometry, transcriptomics, and in vivo muscle-injury models, the authors show that GSK3 inhibition suppresses fat formation while enhancing FAP support of muscle satellite-cell differentiation.

• Chlorin e6 Workflows for PDT Research

  2026-08-24

  Chlorin e6 supports controllable ROS-based experiments spanning anticancer photodynamic therapy and antibacterial wound scaffolds. This guide translates the Ce6 photosensitizer into practical formulation, irradiation, assay, and troubleshooting workflows, including the aligned silk-fibroin platform reported for infected wound healing.

7869 records 1/525 page Next 12345 下5页 Last page